The NuRD Chromatin-Remodeling Enzyme CHD4 Promotes Embryonic Vascular Integrity by Transcriptionally Regulating Extracellular Matrix Proteolysis

PLoS Genetics

Volumn 9, Issue 12, 2013, Pages

  Ingram, Kyle G ^a,b   Curtis, Carol D ^a   Silasi Mansat, Robert ^a   Lupu, Florea ^a,b   Griffin, Courtney T ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN RECEPTOR; CELL PROTEIN; CHROMODOMAIN HELICASE DNA BINDING PROTEIN; CHROMODOMAIN HELICASE DNA BINDING PROTEIN 4; COLLAGEN TYPE 4; FIBRONECTIN; LAMININ; NUCLEOSOME REMODELING AND HISTONE DEACETYLASE; PLASMIN; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR SNF; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL FUNCTION; BLOOD VESSEL RUPTURE; CATALYSIS; CELL ISOLATION; CELL JUNCTION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENOTYPE; HISTONE MODIFICATION; MIDGESTATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; QUANTITATIVE ANALYSIS; TRANSCRIPTION REGULATION; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION;

ANIMALS; BLOOD VESSELS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA HELICASES; EXTRACELLULAR MATRIX; FIBRINOLYSIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOLYSIS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; THROMBOSPONDIN 1; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84892743269     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004031     Document Type: Article

References (72)

1. Davis GE, Senger DR, (2005) Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 97: 1093-1107.
2. Murakami M, Simons M, (2009) Regulation of vascular integrity. J Mol Med 87: 571-582.
3. Sakalihasan N, Limet R, Defawe OD, (2005) Abdominal aortic aneurysm. Lancet 365: 1577-1589.
4. Ruigrok YM, Rinkel GJ, Wijmenga C, (2005) Genetics of intracranial aneurysms. Lancet Neurol 4: 179-189.
5. Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, et al. (2004) Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 131: 1619-1628.
6. Tang N, Mack F, Haase VH, Simon MC, Johnson RS, (2006) pVHL function is essential for endothelial extracellular matrix deposition. Mol Cell Biol 26: 2519-2530.
7. Phoon CK, Aristizabal O, Turnbull DH, (2000) 40 MHz Doppler characterization of umbilical and dorsal aortic blood flow in the early mouse embryo. Ultrasound Med Biol 26: 1275-1283.
8. Chang S, Young BD, Li S, Qi X, Richardson JA, et al. (2006) Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126: 321-334.
9. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, et al. (2001) The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107: 789-800.
10. van Hinsbergh VW, Koolwijk P, (2008) Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res 78: 203-212.
11. Chang CP, Bruneau B, (2011) Epigenetics and Cardiovascular Development. Annu Rev Physiol 74: 41-68.
12. Ohtani K, Dimmeler S, (2011) Epigenetic regulation of cardiovascular differentiation. Cardiovasc Res 90: 404-412.
13. Curtis CD, Davis RB, Ingram KG, Griffin CT, (2012) Chromatin-remodeling complex specificity and embryonic vascular development. Cell Mol Life Sci 69: 3921-3931.
14. van Weerd JH, Koshiba-Takeuchi K, Kwon C, Takeuchi JK, (2011) Epigenetic factors and cardiac development. Cardiovasc Res 91: 203-211.
15. Tong JK, Hassig CA, Schnitzler GR, Kingston RE, Schreiber SL, (1998) Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395: 917-921.
16. Wade PA, Jones PL, Vermaak D, Wolffe AP, (1998) A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase. Curr Biol 8: 843-846.
17. Xue Y, Wong J, Moreno GT, Young MK, Cote J, et al. (1998) NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 2: 851-861.
18. Zhang Y, LeRoy G, Seelig HP, Lane WS, Reinberg D, (1998) The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 95: 279-289.
19. Lai AY, Wade PA, (2011) Cancer biology and NuRD: a multifaceted chromatin remodelling complex. Nat Rev Cancer 11: 588-596.
20. Williams CJ, Naito T, Arco PG, Seavitt JR, Cashman SM, et al. (2004) The chromatin remodeler Mi-2beta is required for CD4 expression and T cell development. Immunity 20: 719-733.
21. Miccio A, Wang Y, Hong W, Gregory GD, Wang H, et al. (2010) NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development. Embo J 29: 442-456.
22. Hung H, Kohnken R, Svaren J, (2012) The nucleosome remodeling and deacetylase chromatin remodeling (NuRD) complex is required for peripheral nerve myelination. J Neurosci 32: 1517-1527.
23. Curtis CD, Griffin CT, (2012) The chromatin-remodeling enzymes BRG1 and CHD4 antagonistically regulate vascular Wnt signaling. Mol Cell Biol 32: 1312-1320.
24. Coultas L, Chawengsaksophak K, Rossant J, (2005) Endothelial cells and VEGF in vascular development. Nature 438: 937-945.
25. Stankunas K, Hang CT, Tsun ZY, Chen H, Lee NV, et al. (2008) Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev Cell 14: 298-311.
26. Meyer D, Birchmeier C, (1995) Multiple essential functions of neuregulin in development. Nature 378: 386-390.
27. Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, et al. (1995) Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378: 390-394.
28. Lee KF, Simon H, Chen H, Bates B, Hung MC, et al. (1995) Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378: 394-398.
29. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, et al. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 1171-1180.
30. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, et al. (2000) Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 106: 349-360.
31. Cattelino A, Liebner S, Gallini R, Zanetti A, Balconi G, et al. (2003) The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J Cell Biol 162: 1111-1122.
32. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO, (1993) Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119: 1079-1091.
33. Orr AW, Lee MY, Lemmon JA, Yurdagul A Jr, Gomez MF, et al. (2009) Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 29: 225-231.
34. Armulik A, Abramsson A, Betsholtz C, (2005) Endothelial/pericyte interactions. Circ Res 97: 512-523.
35. Holycross BJ, Blank RS, Thompson MM, Peach MJ, Owens GK, (1992) Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res 71: 1525-1532.
36. Corjay MH, Thompson MM, Lynch KR, Owens GK, (1989) Differential effect of platelet-derived growth factor- versus serum-induced growth on smooth muscle alpha-actin and nonmuscle beta-actin mRNA expression in cultured rat aortic smooth muscle cells. J Biol Chem 264: 10501-10506.
37. Blasi F, Sidenius N, (2010) The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling. FEBS Lett 584: 1923-1930.
38. Wang SJ, Greer P, Auerbach R, (1996) Isolation and propagation of yolk-sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-of-function fps/fes proto-oncogene. In Vitro Cell Dev Biol Anim 32: 292-299.
39. Ghosh S, Johnson JJ, Sen R, Mukhopadhyay S, Liu Y, et al. (2006) Functional relevance of urinary-type plasminogen activator receptor-alpha3beta1 integrin association in proteinase regulatory pathways. J Biol Chem 281: 13021-13029.
40. Smith HW, Marshall CJ, (2010) Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 11: 23-36.
41. Reynolds N, Salmon-Divon M, Dvinge H, Hynes-Allen A, Balasooriya G, et al. (2012) NuRD-mediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression. Embo J 31: 593-605.
42. Zhang J, Jackson AF, Naito T, Dose M, Seavitt J, et al. (2012) Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis. Nat Immunol 13: 86-94.
43. Hogg PJ, Stenflo J, Mosher DF, (1992) Thrombospondin is a slow tight-binding inhibitor of plasmin. Biochemistry 31: 265-269.
44. Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J, et al. (2001) Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl acad Sci U S A 98: 12485-12490.
45. Vassalli JD, Sappino AP, Belin D, (1991) The plasminogen activator/plasmin system. J Clin Invest 88: 1067-1072.
46. Vassalli JD, Belin D, (1987) Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 214: 187-191.
47. Carmeliet P, Moons L, Lijnen R, Baes M, Lemaitre V, et al. (1997) Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 17: 439-444.
48. Bacharach E, Itin A, Keshet E, (1992) In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci U S A 89: 10686-10690.
49. Mazar AP, Henkin J, Goldfarb RH, (1999) The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis 3: 15-32.
50. Bugge TH, Flick MJ, Daugherty CC, Degen JL, (1995) Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 9: 794-807.
51. Ploplis VA, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, et al. (1995) Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 92: 2585-2593.
52. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, et al. (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368: 419-424.
53. Bugge TH, Suh TT, Flick MJ, Daugherty CC, Romer J, et al. (1995) The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem 270: 16886-16894.
54. Davis GE, Pintar Allen KA, Salazar R, Maxwell SA, (2001) Matrix metalloproteinase-1 and-9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J Cell Sci 114: 917-930.
55. Davis GE, Saunders WB, (2006) Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. J Investig Dermatol Symp Proc 11: 44-56.
56. Saunders WB, Bayless KJ, Davis GE, (2005) MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci 118: 2325-2340.
57. Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, et al. (1993) Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest 92: 2756-2760.
58. Dougherty KM, Pearson JM, Yang AY, Westrick RJ, Baker MS, et al. (1999) The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival. Proc Natl Acad Sci U S A 96: 686-691.
59. Dewerchin M, Collen D, Lijnen HR, (2001) Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1. Thromb Haemost 86: 640-646.
60. Lijnen HR, (2001) Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 86: 324-333.
61. Patel MK, Lymn JS, Clunn GF, Hughes AD, (1997) Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17: 2107-2114.
62. Lawler J, Sunday M, Thibert V, Duquette M, George EL, et al. (1998) Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101: 982-992.
63. Shattil SJ, (1995) Function and regulation of the beta 3 integrins in hemostasis and vascular biology. Thromb Haemost 74: 149-155.
64. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, et al. (1999) Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 103: 229-238.
65. Corada M, Nyqvist D, Orsenigo F, Caprini A, Giampietro C, et al. (2010) The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev Cell 18: 938-949.
66. MacSweeney ST, Powell JT, Greenhalgh RM, (1994) Pathogenesis of abdominal aortic aneurysm. Br J Surg 81: 935-941.
67. Carmeliet P, (2000) Proteinases in cardiovascular aneurysms and rupture: targets for therapy? J Clin Invest 105: 1519-1520.
68. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, et al. (2001) Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 230: 230-242.
69. Griffin CT, Curtis CD, Davis RB, Muthukumar V, Magnuson T, (2011) The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels. Proc Natl Acad Sci U S A 108: 2282-2287.
70. Griffin CT, Brennan J, Magnuson T, (2008) The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development. Development 135: 493-500.
71. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, et al. (1999) Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98: 147-157.
72. Schlaeger TM, Qin Y, Fujiwara Y, Magram J, Sato TN, (1995) Vascular endothelial cell lineage-specific promoter in transgenic mice. Development 121: 1089-1098.